Selected research
Industry Growth & Trends
Global GMP Lentivirus Production Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global GMP Lentivirus Production Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for GMP Lentivirus Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for GMP Lentivirus Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for GMP Lentivirus Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the GMP Lentivirus Production Service market include AGC Biologics, Biocompare, BPS Bioscience, Charles River Laboratories, Creative Biogene, Hillgene Biopharma, OXB, ProBio CDMO and ProBioGen AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global GMP Lentivirus Production Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The GMP Lentivirus Production Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global GMP Lentivirus Production Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to GMP Lentivirus Production Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global GMP Lentivirus Production Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
GMP Lentivirus Production Service Market by Company
AGC Biologics
Biocompare
BPS Bioscience
Charles River Laboratories
Creative Biogene
Hillgene Biopharma
OXB
ProBio CDMO
ProBioGen AG
Revvity
SK pharmteco
Thermo Fisher Scientific
VectorBuilder
VIVEbiotech
GMP Lentivirus Production Service Segment by Type
R&D and Preclinical Service
Early Clinical (Phase I/II) Service
Late Clinical and Commercial (Phase III/Launch) Service
GMP Lentivirus Production Service Segment by Application
CAR-T Therapy
Vaccine Development
Gene Editing
Others
GMP Lentivirus Production Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Lentivirus Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP Lentivirus Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Lentivirus Production Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of GMP Lentivirus Production Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- R&D and Preclinical Service
- Early Clinical (Phase I/II) Service
- Late Clinical and Commercial (Phase III/Launch) Service
Applications
- CAR-T Therapy
- Vaccine Development
- Gene Editing
- Others
Companies covered
- AGC Biologics
- Biocompare
- BPS Bioscience
- Charles River Laboratories
- Creative Biogene
- Hillgene Biopharma
- OXB
- ProBio CDMO
- ProBioGen AG
- Revvity
- SK pharmteco
- Thermo Fisher Scientific
- VectorBuilder
- VIVEbiotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global GMP Lentivirus Production Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global GMP Lentivirus Production Service Market Size by Region (2021-2032)
- 1.4.1 Global GMP Lentivirus Production Service Market Size by Region (2021-2026)
- 1.4.2 Global GMP Lentivirus Production Service Market Size by Region (2027-2032)
- 1.5 Key Regions GMP Lentivirus Production Service Market Size (2021-2032)
- 1.5.1 North America GMP Lentivirus Production Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe GMP Lentivirus Production Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific GMP Lentivirus Production Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America GMP Lentivirus Production Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa GMP Lentivirus Production Service Market Size Growth Rate (2021-2032)
2 GMP Lentivirus Production Service Market by Type
- 2.1 Type Introduction
- 2.1.1 R&D and Preclinical Service
- 2.1.2 Early Clinical (Phase I/II) Service
- 2.1.3 Late Clinical and Commercial (Phase III/Launch) Service
- 2.2 Global GMP Lentivirus Production Service Market Size by Type
- 2.2.1 Global GMP Lentivirus Production Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global GMP Lentivirus Production Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global GMP Lentivirus Production Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global GMP Lentivirus Production Service Market Size by Regions
- 2.3.1 North America GMP Lentivirus Production Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe GMP Lentivirus Production Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific GMP Lentivirus Production Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America GMP Lentivirus Production Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa GMP Lentivirus Production Service Market Size Breakdown by Type (2021-2026)
3 GMP Lentivirus Production Service Market by Application
- 3.1 Type Introduction
- 3.1.1 CAR-T Therapy
- 3.1.2 Vaccine Development
- 3.1.3 Gene Editing
- 3.1.4 Others
- 3.2 Global GMP Lentivirus Production Service Market Size by Application
- 3.2.1 Global GMP Lentivirus Production Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global GMP Lentivirus Production Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global GMP Lentivirus Production Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global GMP Lentivirus Production Service Market Size by Regions
- 3.3.1 North America GMP Lentivirus Production Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe GMP Lentivirus Production Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific GMP Lentivirus Production Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America GMP Lentivirus Production Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa GMP Lentivirus Production Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 GMP Lentivirus Production Service Industry Trends
- 4.2 GMP Lentivirus Production Service Industry Drivers
- 4.3 GMP Lentivirus Production Service Industry Opportunities and Challenges
- 4.4 GMP Lentivirus Production Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by GMP Lentivirus Production Service Revenue (2021-2026)
- 5.2 Global GMP Lentivirus Production Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global GMP Lentivirus Production Service Key Company Headquarters & Area Served
- 5.4 Global GMP Lentivirus Production Service Company, Product Type & Application
- 5.5 Global GMP Lentivirus Production Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global GMP Lentivirus Production Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 GMP Lentivirus Production Service Players Market Share by Revenue in 2025
- 5.6.3 2025 GMP Lentivirus Production Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 AGC Biologics
- 6.1.1 AGC Biologics Company Information
- 6.1.2 AGC Biologics Business Overview
- 6.1.3 AGC Biologics GMP Lentivirus Production Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 AGC Biologics GMP Lentivirus Production Service Product Portfolio
- 6.1.5 AGC Biologics Recent Developments
- 6.2 Biocompare
- 6.2.1 Biocompare Company Information
- 6.2.2 Biocompare Business Overview
- 6.2.3 Biocompare GMP Lentivirus Production Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Biocompare GMP Lentivirus Production Service Product Portfolio
- 6.2.5 Biocompare Recent Developments
- 6.3 BPS Bioscience
- 6.3.1 BPS Bioscience Company Information
- 6.3.2 BPS Bioscience Business Overview
- 6.3.3 BPS Bioscience GMP Lentivirus Production Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 BPS Bioscience GMP Lentivirus Production Service Product Portfolio
- 6.3.5 BPS Bioscience Recent Developments
- 6.4 Charles River Laboratories
- 6.4.1 Charles River Laboratories Company Information
- 6.4.2 Charles River Laboratories Business Overview
- 6.4.3 Charles River Laboratories GMP Lentivirus Production Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Charles River Laboratories GMP Lentivirus Production Service Product Portfolio
- 6.4.5 Charles River Laboratories Recent Developments
- 6.5 Creative Biogene
- 6.5.1 Creative Biogene Company Information
- 6.5.2 Creative Biogene Business Overview
- 6.5.3 Creative Biogene GMP Lentivirus Production Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Creative Biogene GMP Lentivirus Production Service Product Portfolio
- 6.5.5 Creative Biogene Recent Developments
- 6.6 Hillgene Biopharma
- 6.6.1 Hillgene Biopharma Company Information
- 6.6.2 Hillgene Biopharma Business Overview
- 6.6.3 Hillgene Biopharma GMP Lentivirus Production Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Hillgene Biopharma GMP Lentivirus Production Service Product Portfolio
- 6.6.5 Hillgene Biopharma Recent Developments
- 6.7 OXB
- 6.7.1 OXB Company Information
- 6.7.2 OXB Business Overview
- 6.7.3 OXB GMP Lentivirus Production Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 OXB GMP Lentivirus Production Service Product Portfolio
- 6.7.5 OXB Recent Developments
- 6.8 ProBio CDMO
- 6.8.1 ProBio CDMO Company Information
- 6.8.2 ProBio CDMO Business Overview
- 6.8.3 ProBio CDMO GMP Lentivirus Production Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 ProBio CDMO GMP Lentivirus Production Service Product Portfolio
- 6.8.5 ProBio CDMO Recent Developments
- 6.9 ProBioGen AG
- 6.9.1 ProBioGen AG Company Information
- 6.9.2 ProBioGen AG Business Overview
- 6.9.3 ProBioGen AG GMP Lentivirus Production Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 ProBioGen AG GMP Lentivirus Production Service Product Portfolio
- 6.9.5 ProBioGen AG Recent Developments
- 6.10 Revvity
- 6.10.1 Revvity Company Information
- 6.10.2 Revvity Business Overview
- 6.10.3 Revvity GMP Lentivirus Production Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Revvity GMP Lentivirus Production Service Product Portfolio
- 6.10.5 Revvity Recent Developments
- 6.11 SK pharmteco
- 6.11.1 SK pharmteco Company Information
- 6.11.2 SK pharmteco Business Overview
- 6.11.3 SK pharmteco GMP Lentivirus Production Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 SK pharmteco GMP Lentivirus Production Service Product Portfolio
- 6.11.5 SK pharmteco Recent Developments
- 6.12 Thermo Fisher Scientific
- 6.12.1 Thermo Fisher Scientific Company Information
- 6.12.2 Thermo Fisher Scientific Business Overview
- 6.12.3 Thermo Fisher Scientific GMP Lentivirus Production Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Thermo Fisher Scientific GMP Lentivirus Production Service Product Portfolio
- 6.12.5 Thermo Fisher Scientific Recent Developments
- 6.13 VectorBuilder
- 6.13.1 VectorBuilder Company Information
- 6.13.2 VectorBuilder Business Overview
- 6.13.3 VectorBuilder GMP Lentivirus Production Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 VectorBuilder GMP Lentivirus Production Service Product Portfolio
- 6.13.5 VectorBuilder Recent Developments
- 6.14 VIVEbiotech
- 6.14.1 VIVEbiotech Company Information
- 6.14.2 VIVEbiotech Business Overview
- 6.14.3 VIVEbiotech GMP Lentivirus Production Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 VIVEbiotech GMP Lentivirus Production Service Product Portfolio
- 6.14.5 VIVEbiotech Recent Developments
7 North America
- 7.1 North America GMP Lentivirus Production Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America GMP Lentivirus Production Service Market Size by Country (2021-2026)
- 7.3 North America GMP Lentivirus Production Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe GMP Lentivirus Production Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe GMP Lentivirus Production Service Market Size by Country (2021-2026)
- 8.3 Europe GMP Lentivirus Production Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific GMP Lentivirus Production Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific GMP Lentivirus Production Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific GMP Lentivirus Production Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America GMP Lentivirus Production Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America GMP Lentivirus Production Service Market Size by Country (2021-2026)
- 10.3 South America GMP Lentivirus Production Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa GMP Lentivirus Production Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa GMP Lentivirus Production Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa GMP Lentivirus Production Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst